Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Packard

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Lipidology|September 17, 2024
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round TableFrançois Mach, Frank L J Visseren, Nilo B Cater, et al.
Lancet (London, England)|February 14, 2012
Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosomeFadi J Charchar, Lisa Ds Bloomer, Timothy A Barnes, et al.
JAMA Cardiology|June 22, 2018
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization AnalysisStephen Burgess, Brian A Ference, James R Staley, et al.
Science (New York, N.Y.)|March 12, 2016
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseasePaolo Zanoni, Sumeet A Khetarpal, Daniel B Larach, et al.
JAMA|July 17, 2012
Lipid-related markers and cardiovascular disease prediction, Emanuele Di Angelantonio, Pei Gao, et al.
Circulation|December 23, 2009
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphismsReecha Sofat, Aroon D Hingorani, Liam Smeeth, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Lipidology|September 17, 2024
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round TableFrançois Mach, Frank L J Visseren, Nilo B Cater, et al.
Lancet (London, England)|February 14, 2012
Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosomeFadi J Charchar, Lisa Ds Bloomer, Timothy A Barnes, et al.
JAMA Cardiology|June 22, 2018
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization AnalysisStephen Burgess, Brian A Ference, James R Staley, et al.
Science (New York, N.Y.)|March 12, 2016
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseasePaolo Zanoni, Sumeet A Khetarpal, Daniel B Larach, et al.
JAMA|July 17, 2012
Lipid-related markers and cardiovascular disease prediction, Emanuele Di Angelantonio, Pei Gao, et al.
Circulation|December 23, 2009
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphismsReecha Sofat, Aroon D Hingorani, Liam Smeeth, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Pageof 3